This page is dedicated to IRBNet specifics for IBC (Institutional Biosafety Committee) submissions. For help with general IRBNet navigation, such as creating a new project, accessing required materials, etc., please refer to our IRBNet Basics/Pro guidance here
Frequently Asked Questions (FAQs)
The IBC meets as necessary. There are no submission deadlines because of the infrequency of IBC meetings.
Any work that falls under Section III-A, B, C, D, or E of the NIH Guidelines, involves the use of infectious organisms included in Risk Groups 3 and 4, or the use of Select Agents and Toxins will a require review by a convened committee.
The process after FCR depends on committee review and votes. Protocols can be either Approved, Modifications Required, or Withhold Approval. If the project is approved, the Investigator receives an electronic letter via IRBNet stating their protocol is approved, and research activities can begin (provided you are not waiting on IACUC approval). If the project requires modifications, a letter is sent via IRBNet to the Investigator. The letter details the information required to secure IBC approval. If Withhold Approval is the outcome, the Investigator is notified via IRBNet through a letter. If approval is withheld, the Investigator has the option to submit a new protocol. The new submission would be reviewed at the next FCR meeting. For additional guidance with general IRBNet navigation, such as submitting a follow-up response and accessing Board Documents, please refer to our IRBNet Basics/Pro guidance here.
Yes. Regardless of the funding source, all recombinant DNA research must be reviewed by the IBC. The University of South Alabama receives funding from NIH grants; ALL recombinant DNA research conducted at the University must comply with NIH Guidelines and Institutional policies.
Research projects that use similar biohazards in a similar manner do not require separate registrations. However, if the research project involves a substantial change to the current and approved protocol, an amendment or a new IBC protocol application may be applicable.
No. Protocols are approved for three (3) years only. The approval date of a modification does not alter the protocol's original approval date.
Yes. Wherever you see a Save and Exit button or Save the form, click on it. You can return to your existing project at any time to complete the documents. For additional guidance on Accessing an Existing Project, please refer to our IRBNet Basics here.
Yes. Regardless of protocol status, the PI will always have access to their protocol (s).
No. IBC approvals only cover the specific research project that was reviewed by the IBC, not the shared space.
Yes. All new labs must be inspected prior to the start of any research activities. New laboratories are inspected two weeks post-approval of the protocol. Download examples below for guidance on new laboratory inspections. If you need additional guidance or have questions, please get in touch with the IBC office.
Download our New Lab Inspection guidance [downloadable forms]
Biosafety spill kits for USA Investigators must contain the following items:
- PPE such as gloves, lab coat, safety goggles
- Broom/dustpan and Tongs (plastic)
- Absorbent paper towels
- Red Biohazard bags
- Appropriate Disinfectants like 10% bleach and/or other decontaminate appropriate for agent in use.
To find out how and where to get a spill kit; contact the Office of Safety and Environmental Compliance at 251-460-7070.
You will notice we use acronyms often or we use two different words, but both have the same meaning. Below are some abbreviations and words with their definition and/or meaning.
IBC: Institutional Biosafety Committee
NIH: National Institutes of Health
BSO: Biological Safety Officer
Proposal: can be called protocol or project
PI: Principal Investigator/Investigator/Researcher
OSPT: Office of Science Technology Policy
RO: Responsible Official
BMBL: Biosafety in Microbiological and Biomedical Laboratories
SEC: Safety and Environmental Compliance
BSL: Biosafety Level
FCR: Full Committee Review
DMR: Designated Member Review
HGT: Human Gene Therapy
ECP: Exposure Control Plan
USDA: United States Department of Agriculture
ARO: Alternate Responsible Official
Have questions not addressed on the FAQ page? Please get in touch with the IBC office by email or call (251) 341-4913